Skip to content

The feasibility and efficacy of intensive home treatment (IHT) as an alternative to acute psychiatric admission.

The feasibility and efficacy of intensive home treatment (IHT) as an alternative to acute psychiatric admission. - Intensive home treatment as an alternative to acute psychiatric admission.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46022
Enrollment
230
Registered
2016-09-09
Start date
2016-12-02
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mental illness psychological disorder

Interventions

IHT is a treatment modality that addresses some of the imperfections of inpatient care by providing care in the patients* home setting, thus maximising the utilization of the patient*s social system

Sponsors

Arkin (Amsterdam)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) A psychiatrist must state that admission to a clinical crisis care department is indicated, if necessary on a compulsory basis. This decision is based on clinical outcomes, opinions of other professionals and informal caregivers. (2) There is at least one axis I or II disorder diagnosed (for example psychotic disorder, bipolar disorder or a personality disorder). (3) The patient is a resident of Amsterdam, Diemen or Driemond, the Netherlands. (4) Written informed consent provided by patient.

Exclusion criteria

Exclusion criteria: (1) Patient is homeless. (2) Primary diagnosis is substance use disorder for which referral to a specialized unit for detoxification is indicated. (3) Currently receiving (F)ACT care. (4) Previous IHT-treatment. (5) Patient age 65.

Design outcomes

Secondary

MeasureTime frame
Secondary outcomes include safety of the patient and his/her direct social environment, mental wellbeing, general functioning, and quality of life. In addition to reporting clinical outcomes and hospitalisation duration, an economic evaluation alongside the RCT is planned.

Primary

MeasureTime frame
The number of hospitalisation days in the 12 months after randomisation. This includes the duration of the initial admission at baseline, and any subsequent psychiatric admission during the follow-up period of the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)